Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Palo Alto Veterans Institute for Research
- Study ID
- NCT07303725
- Status
- Recruiting
Conditions
- Liver Cancer (Primary and Metastatic)
- Renal Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This is a pilot study to evaluate the feasibility, image quality, and procedural utility of a novel spectral CT technique using Canon Medical's 4D CT system during image-guided interventional oncology procedures
Key Dates
- Start date
- Feb 1, 2025
- Status verified
- Mar 2025
- Primary completion
- Feb 1, 2026
- Completion
- Sep 1, 2026
Study Design
- Enrollment
- 30 participants (estimated)
Arms
- Arm: angiography mappingHepatocellular carcinoma (HCC) patients undergoing hepatic angiography mapping prior to TARE (N=10)
- Arm: microwave ablationpercutaneous tumor ablation in patients receiving image-guided tumor ablation using MWA (n=10)
- Arm: cryoablationcryoablation (N=10) for primary liver (HCC) or primary kidney tumors (RCC)
Primary Outcome Measure
CT image [ Time Frame: Baseline ]
Central Contacts
- Sirish Kishore, MD650-493-5000
- Luisa Manfredi, MPH650-493-5000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Palo Alto Healthcare System | Palo Alto | California | 94304 | Sirish Kishore, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Palo Alto, CA
By condition
By research site
Related Studies
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruiting · Adela, Inc · Duarte, California
- 64Cu-GRIP B in Patients With Advanced MalignanciesPHASE1/PHASE2 · Recruiting · Rahul Aggarwal · San Francisco, California
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell CancerPHASE1/PHASE2 · Recruiting · Pfizer · Phoenix, Arizona